Differing Viewpoints: Does FDA Need More Post-Market Authority?
This article was originally published in The Gray Sheet
Executive Summary
Consumer and patient advocates say FDA needs more post-market authorities from Congress for 510(k)-cleared devices, but manufacturers argue that the agency should be able to work with what it has.
You may also be interested in...
Institute Of Medicine On 510(k) Review Program: Dump It
The Institute of Medicine committee charged with reviewing FDA's 510(k) device pre-market review program is urging the agency to ditch the 35-year-old program and start fresh.
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.